7Rossouw JE, Auderson GL, Prentice RL et al. Writing group for the women health initiative investigations risks and benefits of estrogen plus progestin in healthy post menopausal women principal result from the women health initiative randomized and controlled trial[J]. JAMA, 2002, 288 (3): 321.
8Hulley S, Grady D , Bush T et al. Randomized trial of estro- gen plus progestin for secondary prevention of coronary heart disease in postmenopausal women [J]. JAMA, 2002, 288 (7) : 605.
9Manson JE, Allison MA, Rossouw JE et al. Estrogen therapy and coronary artery calcification [J]. N Engl J Med, 2007, 356 (25): 2591.
10Rossouw JE, Prentice RL, Manson JE et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause[J]. JAMA, 2007, 297 (13) : 1465.
7Prasad K. Antioxidant activity of secoisolariciresinol diglucoside- derived metabolites, secoisolariciresinol, enterodiol, and enterolac- tone [ J ]. Int J Angio1,2000,9 (4) :220 - 225.
8Moree SS, Rajesha J. Investigation of in vitro and in vivo antioxi- dant potential of secoisolariciresinol diglucoside [ J ]. Molecular and Cellular Biochemistry ,2013,373 ( 1 - 2 ) : 179 - 187.
